Possible clinical efficacy and tolerability of platelet-rich plasma with atopic dermatitis.

Background: Narrowband-ultraviolet B (NB-UVB) is a promising, effective, and safe therapeutic option for atopic dermatitis (AD), but the treating courses frequently need an extended period since they might have a possible hazard for several side effects and cases of non-compliance.

Objective: To discover the influence of platelet-rich plasma (PRP) injecting on the outcomes of short-term NB-UVB treatment for AD cases.

Patients And Methods: The present study includes 44 atopic dermatitis cases with general symmetric lesions.